Trial Profile
A phase I/IIa trial of BB AMD 211
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 24 Oct 2016
Price :
$35
*
At a glance
- Drugs BB-AMD 211 (Primary)
- Indications Wet age-related macular degeneration
- Focus Adverse reactions; First in man
- 24 Oct 2016 New trial record